This study is looking at people with mycobacterial infections, especially those caused by nontuberculous mycobacteria (NTM). NTM are common germs in the environment that usually don't cause problems, but in some people, they can lead to recurrent lung infections and other issues. Researchers want to understand why some people get these infections by studying their symptoms, how the disease progresses, and their genetics. They are also comparing NTM infections to other conditions like Job syndrome and cystic fibrosis. The study aims to identify problems with the immune system that make people more likely to get these infections. Clofazimine is mentioned as an intervention, but the study primarily focuses on observation.

Study design

This is an observational study planning to enroll 1000 participants. It is not a drug trial testing a specific treatment, but rather a study to learn more about the disease.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint is measured at ongoing, suggesting continuous observation.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.